『Skin and Joints Podcast』のカバーアート

Skin and Joints Podcast

Skin and Joints Podcast

著者： Mimi Tran Aaron Sihota Danny Mansour Ashley Yip Julia Tan Touraj Khosravi Anastasiya Muntyanu
無料で聴く

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり
A national multidisciplinary masterclass exploring inflammatory skin and joint related conditions led by healthcare experts from across Canada and the US.2026 Skin and Joints Podcast 生物科学 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Beyond Skin Deep & Gut Feelings: Mastering IBD and Psoriatic Care PART 3

    Beyond Skin Deep & Gut Feelings: Mastering IBD and Psoriatic Care PART 3
    2026/07/28
    Part 3 of 3: Our Practical Playbook When Skin & Gut Don’t Read the Same Treatment PlanWhat happens when the skin is crystal clear…but the Crohn’s disease didn’t get the memo? 👀In the final chapter of our special Derm × GI crossover conversation, our Faculty Dr. Perry Grewal and Dr. Jesse Siffledeen get practical about what happens after the prescription is written.From treat-to-target monitoring and follow-up cadence to the very real influence of insurance requirements, our experts unpack how they decide whether a therapy is truly working—and what to do when different organ systems are telling very different stories.🧩 Great skin, active gut?🧩 Controlled IBD, stubborn psoriasis?🧩 One therapy, two diseases…or occasionally two therapies?The conversation explores how clinicians prioritize competing treatment targets without sacrificing what matters most to the patient, why success may need to be measured beyond a single organ system, and where communication between specialties becomes essential.And perhaps the simplest clinical pearl of the entire series? Ask the questions—and don’t be afraid to pick up the phone.Because when inflammatory disease crosses specialties, the best care probably should too. 🎯 Learning ObjectivesAfter listening to this episode, participants should be able to:Describe practical approaches to monitoring treatment response across dermatologic and gastrointestinal inflammatory diseases, including the role of early clinical follow-up and objective assessment.Evaluate therapeutic options when disease control differs across organ systems, such as controlled psoriasis with active IBD or controlled IBD with persistent skin disease.Discuss the limitations of organ-specific treatment targets and incorporate patient priorities, disease severity, and multisystem outcomes when defining therapeutic success.Recognize how payer and insurance requirements can influence treatment selection, reassessment schedules, access, and consideration of dual therapy.Identify key questions that dermatology and gastroenterology clinicians can ask to recognize disease manifestations outside their own specialty and facilitate timely referral.Apply practical strategies for multidisciplinary co-management, including direct clinician-to-clinician communication and collaborative treatment decision-making,🔥 In This Episode🔬 Treat-to-target: when should you actually reassess?🎯 One patient, two organs: does success require both to be at target?🔄 Great skin, active gut—or vice versa: when do you switch?💊 Dual therapy: useful tool or access nightmare?💰 When insurance starts influencing the clinical calendar🗣️ Why asking about the gut–skin–joint connection matters📞 The underrated power of simply calling your colleague🤝 Why multidisciplinary care needs to move from concept to everyday workflow #SkinAndJoints #Dermatology #Gastroenterology #IBD #CrohnsDisease #Psoriasis #SkinGutAxis #TreatToTarget #Biologics #IL23 #InflammatoryDisease #MultidisciplinaryCare #PrecisionMedicine #PatientCentredCare #MedicalEducation #HCPeducation SUPPORTED BY AN IME GRANT FROM JnJ Johnson and Johnson. ABOUT Dr. Parbeer GrewalDermatologist, Edmonton, ABDr. Parbeer Grewal completed his Bachelor of Science undergraduate degree at the University of Alberta with a specialization in Psychology and graduated with distinction. He completed his Doctorate of Medicine degree at the University of Alberta and graduated with Special Training in Research. He completed dermatology training at the University of Alberta and became a Fellow of the Royal College of Physicians and Surgeons of Canada and a board-certified Fellow of the American Academy of Dermatology. Dr. Grewal is an Associate Clinical Professor within the University of Alberta’s Faculty of Medicine - Dermatology. In addition to working at Rejuvenation, he is a consulting physician for the University of Alberta Hospital, the Royal Alexandra Hospital, the Grey Nuns Hospital and the Misericordia Hospital. Dr. Grewal has participated in over 60 clinical research trials for a multitude of dermatology conditions and medications. In addition, Dr. Grewal serves on multiple national and international scientific advisory boards, is a distinguished peer reviewer for medical journals and has published both journal articles and book chapters in dermatology. He has specific interests in psoriasis, acne, eczema, warts, skin cancers, rashes and moles. He offers a wide range of topical and systemic therapy along with surgical and aesthetic services. ABOUT Dr. Jesse Siffledeen, MD, FRCPC Gastroenterology, Edmonton, ABDr. Siffledeen is a clinical professor in the Division of Gastroenterology at the University of Alberta. He is also currently the past-president of the Alberta Society of Gastroenterology. He has established a large clinical IBD practice in Edmonton and is the director of the South Edmonton Gastroenterology Research Unit...
    続きを読む 一部表示
    19 分
  • Beyond Skin Deep & Gut Feelings: Mastering IBD and Psoriatic Care PART 2

    Beyond Skin Deep & Gut Feelings: Mastering IBD and Psoriatic Care PART 2
    2026/07/21
    🎙️ Beyond Skin Deep & Gut Feelings — Part 2: When the Gut and Skin Share the Treatment PlanOne patient. Two organ systems. And suddenly, choosing a biologic gets a whole lot more interesting. 👀In Part 2 of our Derm × GI crossover, podcast Faculty members dermatologist Dr. Perry Grewal and gastroenterologist Dr. Jesse Siffledeen move from diagnosis into the real-world treatment decisions that happen when psoriasis and inflammatory bowel disease collide.PRO-TIPS COVERED: How do you practically choose one therapy when you’re treating two inflammatory diseases? When might suspected IBD steer a dermatologist away from an IL-17 inhibitor? What happens when the dose needed for Crohn’s disease doesn’t match the dose used for psoriasis? And when one drug isn’t enough, is dual advanced therapy the next frontier—or an insurance headache waiting to happen? 😅The conversation also digs into the very different therapeutic ceilings in dermatology and gastroenterology, including emerging data in perianal Crohn’s disease, the challenge of achieving true mucosal healing, and why GI may still be chasing remission rates that dermatology has already learned to expect from modern psoriasis therapy.It gets practical: Who owns the prescription? Who takes the lead when one organ system flares? How much communication is really needed between specialists? And where do vaccinations fit when advanced therapy needs to start quickly?From IL-23s vs IL-17s to biologic dosing, multidisciplinary care, vaccine timing and the occasional therapeutic turf war, this is where “shared care” leaves the PowerPoint slide and enters actual clinical practice. 🧩🎯 Learning ObjectivesAfter listening to this episode, participants should be able to:Compare key clinical factors that influence advanced therapy selection in patients with psoriasis and coexisting or suspected inflammatory bowel disease.Explain how IL-17, IL-23 and TNF-targeted therapies may be approached differently when Crohn’s disease, fistulizing disease or possible IBD is part of the clinical picture.Discuss real-world challenges in multidisciplinary treatment, including differing doses across indications, prescription ownership, reimbursement barriers and situations where dual advanced therapy may be considered.Contrast treatment targets in psoriasis and IBD, including PASI-based skin clearance versus clinical remission, endoscopic improvement and mucosal healing.Identify practical approaches to vaccination and treatment onboarding for patients starting biologic or other advanced systemic therapies.🎧 Part 2 of 3 — stay tuned for Part 3 as the conversation moves into monitoring and treat-to-target across the skin–gut axis.#SkinAndJoints #Dermatology #Gastroenterology #IBD #CrohnsDisease #Psoriasis #SkinGutAxis #Biologics #IL23 #IL17 #TNFInhibitors #InflammatoryDisease #PrecisionMedicine #MultidisciplinaryCare #MedicalEducation #HCPeducation 🧬🩺💊 SUPPORTED BY AN IME GRANT FROM JnJ Johnson and Johnson. ABOUT Dr. Parbeer GrewalDermatologist, Edmonton, ABDr. Parbeer Grewal completed his Bachelor of Science undergraduate degree at the University of Alberta with a specialization in Psychology and graduated with distinction. He completed his Doctorate of Medicine degree at the University of Alberta and graduated with Special Training in Research. He completed dermatology training at the University of Alberta and became a Fellow of the Royal College of Physicians and Surgeons of Canada and a board-certified Fellow of the American Academy of Dermatology. Dr. Grewal is an Associate Clinical Professor within the University of Alberta’s Faculty of Medicine - Dermatology. In addition to working at Rejuvenation, he is a consulting physician for the University of Alberta Hospital, the Royal Alexandra Hospital, the Grey Nuns Hospital and the Misericordia Hospital. Dr. Grewal has participated in over 60 clinical research trials for a multitude of dermatology conditions and medications. In addition, Dr. Grewal serves on multiple national and international scientific advisory boards, is a distinguished peer reviewer for medical journals and has published both journal articles and book chapters in dermatology. He has specific interests in psoriasis, acne, eczema, warts, skin cancers, rashes and moles. He offers a wide range of topical and systemic therapy along with surgical and aesthetic services. ABOUT Dr. Jesse Siffledeen, MD, FRCPC Gastroenterology, Edmonton, ABDr. Siffledeen is a clinical professor in the Division of Gastroenterology at the University of Alberta. He is also currently the past-president of the Alberta Society of Gastroenterology. He has established a large clinical IBD practice in Edmonton and is the director of the South Edmonton Gastroenterology Research Unit, serving as principal investigator and collaborator on several IBD-related clinical trials for over 20 years. He is an active collaborator in the Edmonton IBD ...
    続きを読む 一部表示
    24 分
  • Beyond Skin Deep & Gut Feelings: Mastering IBD and Psoriatic Care PART 1

    Beyond Skin Deep & Gut Feelings: Mastering IBD and Psoriatic Care PART 1
    2026/07/14
    Not every loose stool is Crohn’s. Not every rash is “just a rash.” And sometimes the most useful clinical tool is knowing exactly which colleague to text.In Part 1 of our special Skin and Joints Podcast crossover, we go beyond skin deep and gut feelings with dermatologist Dr. Perry Grewal and gastroenterologist Dr. Jesse Siffledeen to tackle what Derm–GI collaboration actually looks like, or could look like in the real world.Psoriasis and inflammatory bowel disease may live in different specialty clinics, but for many patients, the boundaries aren’t nearly so tidy.What should make a dermatologist start thinking about the gut? Which GI symptoms deserve a routine referral—and which ones should make your clinical “spidey sense” start tingling?Our guest experts get practical about:🔎 The GI red flags worth screening for in patients with psoriatic disease🚨 When a referral can wait—and when it probably shouldn’t🧪 Where fecal calprotectin, inflammatory markers and anemia fit into the picture📲 Why sometimes a colleague’s name, and a quick message can be more useful than an elaborate referral pathway📝 What actually needs to go into a useful Derm-to-GI or GI-to-Derm referral🧩 How to begin separating IBD from common mimics such as IBS and post-infectious symptoms💊 Why recognizing coexisting immune-mediated disease can influence treatment decisionsAnd perhaps most importantly: multidisciplinary care doesn’t always require a multidisciplinary clinic.🎯 Learning ObjectivesBy the end of Part 1, listeners should be able to:Recognize key gastrointestinal signs, symptoms and clinical red flags that may warrant further investigation for IBD in a patient presenting with psoriatic disease.Differentiate between routine, urgent and potentially emergent GI referral scenarios based on symptoms, systemic illness and available objective findings.Describe practical strategies for Derm–GI co-management, including effective communication and the essential information to include when referring between specialties.Explain how suspected or confirmed gastrointestinal comorbidity may influence therapeutic decision-making in patients with immune-mediated disease.Identify clinical features that can help distinguish IBD from common gastrointestinal mimics, while recognizing when specialist assessment is warranted.🎧 Two specialties. One patient. And a lot more overlap than the clinic schedule might suggest.#SkinAndJointsPodcast #Dermatology #Gastroenterology #Psoriasis #IBD #CrohnsDisease #UlcerativeColitis #ImmuneMediatedDisease #MultidisciplinaryCare #MedicalEducation #DermGI #ClinicalPracticeSUPPORTED BY AN IME GRANT FROM JnJ Johnson and Johnson. ABOUT Dr. Parbeer GrewalDermatologist, Edmonton, ABDr. Parbeer Grewal completed his Bachelor of Science undergraduate degree at the University of Alberta with a specialization in Psychology and graduated with distinction. He completed his Doctorate of Medicine degree at the University of Alberta and graduated with Special Training in Research. He completed dermatology training at the University of Alberta and became a Fellow of the Royal College of Physicians and Surgeons of Canada and a board-certified Fellow of the American Academy of Dermatology. Dr. Grewal is an Associate Clinical Professor within the University of Alberta’s Faculty of Medicine - Dermatology. In addition to working at Rejuvenation, he is a consulting physician for the University of Alberta Hospital, the Royal Alexandra Hospital, the Grey Nuns Hospital and the Misericordia Hospital. Dr. Grewal has participated in over 60 clinical research trials for a multitude of dermatology conditions and medications. In addition, Dr. Grewal serves on multiple national and international scientific advisory boards, is a distinguished peer reviewer for medical journals and has published both journal articles and book chapters in dermatology. He has specific interests in psoriasis, acne, eczema, warts, skin cancers, rashes and moles. He offers a wide range of topical and systemic therapy along with surgical and aesthetic services. ABOUT Dr. Jesse Siffledeen, MD, FRCPC Gastroenterology, Edmonton, ABDr. Siffledeen is a clinical professor in the Division of Gastroenterology at the University of Alberta. He is also currently the past-president of the Alberta Society of Gastroenterology. He has established a large clinical IBD practice in Edmonton and is the director of the South Edmonton Gastroenterology Research Unit, serving as principal investigator and collaborator on several IBD-related clinical trials for over 20 years. He is an active collaborator in the Edmonton IBD research community and as a member of the Canadian IBD research consortium.Dr. Siffledeen completed his Gastroenterology studies at the University of Alberta in 2010 and inflammatory bowel disease research/Master’s degree at the University of Oxford in 2011. 📻www.skinandjoints.ca✉️info@skinandjoints.ca ...
    続きを読む 一部表示
    25 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません